[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353240-105":59,"doc-detail-353240-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","heat-shock-protein-90-from-molecular-chaperone-function-to-therapeutic-targeting-in-malignancies","Heat Shock Protein 90: From Molecular Chaperone Function to Therapeutic Targeting in Malignancies","","Heat shock protein 90 (HSP90) is an evolutionarily conserved molecular chaperone central to cellular proteostasis and stress adaptation. By enabling protein folding and client activation, it supports development, proliferation, differentiation, and stress responses. In cancer, HSP90 creates tumor dependency by sustaining oncogenic signaling, buffering proteotoxic stress, and surviving therapeutic insults. This review links HSP90’s molecular roles to cancer pathology and therapeutic resistance, summarizing mechanisms and context-dependent functions in progression, drug resistance, and immune regulation, and highlighting emerging HSP90-targeted interventions and resistance-aware strategies for translation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/heat-shock-protein-90-from-molecular-chaperone-function-to-therapeutic-targeting-in-malignancies/353240/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/heat-shock-protein-90-from-molecular-chaperone-function-to-therapeutic-targeting-in-malignancies/353240.png","ImageObject",300,407,{"name":92,"@type":93},"Fans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What roles does HSP90 play in cellular proteostasis and stress adaptation?","Question",{"text":112,"@type":113},"HSP90 functions as a molecular chaperone that promotes protein folding and supports activation of many client proteins, helping cells maintain proteostasis and respond to stress.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why are tumor cells highly dependent on HSP90?",{"text":117,"@type":113},"In cancer, HSP90 helps maintain oncogenic signaling, buffers proteotoxic stress, and supports survival under therapeutic insults, thereby promoting therapeutic resistance and recurrence.",{"name":119,"@type":110,"acceptedAnswer":120},"What challenges have limited early HSP90 inhibitor development?",{"text":121,"@type":113},"Early HSP90 inhibitors, including geldanamycin and derivatives, faced dose-limiting systemic toxicities and unintended activation of a compensatory heat shock response that can reduce antitumor efficacy and support adaptive resistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353240,1790525275,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Advanced Science  \n| [www.advancedscience.com](www.advancedscience.com)\u003Cbr> REVIEW \u003Cbr>Heat Shock Protein 90: From Molecular Chaperone Function to Therapeutic Targeting in Malignancies\u003Cbr>Beibei Zhang1   Xinxin Zou1  Jiansong Zhou1, 2  Qinmiao Sun3, 4, 5  Dahua Chen1, 2 \u003Cbr>1 Institute of Biomedical Research, Yunnan University, Kunming, Yunnan, China  2 Southwest United Graduate School, Kunming, China  3 State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing, China  4 Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China  5 School of Life Sciences, University of Chinese Academy of Sciences, Beijing, China\u003Cbr>Correspondence: Beibei Zhang ([zhangb@ynu.edu.cn](zhangb@ynu.edu.cn))  Qinmiao Sun (qinmiaosun@ioz.ac.cn)  Dahua Chen (chendh@ynu.edu.cn)\u003Cbr>Received: 15 December 2025  Revised: 7 May 2026  Accepted: 21 May 2026\u003Cbr>Keywords: cancer recurrence | drug resistance | heat shock protein | immunotherapy | molecular chaperone\u003Cbr>\u003Cbr>ABSTRACT\u003Cbr>Heat shock protein 90 (HSP90) is an evolutionarily conserved molecular chaperone that occupies a central position in cellular proteostasis and adaptation to stress. By promoting protein folding and facilitating the functional activation of a broad repertoire of clients, HSP90 underpins essential cellular processes, including development, proliferation, differentiation, and stress responses. In cancer, this extensive network renders tumor cells highly dependent on HSP90 to maintain oncogenic signaling, tolerate proteotoxic stress, and survive therapeutic insults. In this review, we propose an integrated conceptual framework linking HSP90’s molecular chaperone functions to its pathological roles in cancer: HSP90 serves as a central node that concurrently supports oncogenic signaling, buffers proteotoxic stress, maintains cancer stem cell plasticity, and shapes tumor-immune interactions-all of which converge to drive therapeutic resistance and tumor recurrence. Within this framework, we summarize the molecular mechanisms governing HSP90 activity and dissect its context-dependent roles in cancer progression, drug resistance, and immune regulation. We further highlight recent advances in HSP90-targeted interventions, including small-molecule inhibitors, monoclonal antibodies, engineered immune cells, and emerging strategies designed to prevent, delay, or overcome drug resistance. Taken together, these developments underscore HSP90 as a versatile therapeutic node and point toward innovative, resistance-aware strategies for clinical translation and future research. |  |\n| --- | --- |\n| 1  Introduction\u003Cbr>Heat shock proteins (HSPs) are essential molecular chaperones that preserve protein homeostasis under both physiological and stress conditions [1–3] . In disease states, particularly within the tumor microenvironment (TME), which is characterized by hypoxia, nutrient deprivation, acidosis, chronic inflammation, and exposure to chemotherapeutic agents, proteotoxic stress is heightened, and HSPs are robustly induced to buffer damage and sustain cell viability [1–4] . In this context, HSPs do | not merely act as passive protectors of proteome integrity but become active enablers of malignant progression and therapeutic failure. By stabilizing mutated, overexpressed, or misfolded oncoproteins and stress-survival factors, they help tumor cells withstand cytotoxic chemotherapy, targeted agents, endocrine therapies, radiotherapy, and immunotherapies, thereby driving both primary refractoriness and acquired drug resistance [5, 6] .\u003Cbr>Among them, the 90 kDa heat shock protein (HSP90) has emerged as a central node in the chaperone network and a com- |\n| Beibei Zhang, Xinxin Zou, and Jiansong Zhou contributed equally to this work. |  |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is p","cbCailYU9HE38pdS","https://ap.wps.com/l/cbCailYU9HE38pdS","pdf",5029005,28,"English","# Introduction\n## Heat shock proteins and proteotoxic stress in the tumor microenvironment\n## HSP90 as a central chaperone node and cancer dependency\n## HSP90 client proteins and mechanisms of oncogenic signaling\n## Limitations of early HSP90 inhibitors and heat shock response","[{\"question\":\"What roles does HSP90 play in cellular proteostasis and stress adaptation?\",\"answer\":\"HSP90 functions as a molecular chaperone that promotes protein folding and supports activation of many client proteins, helping cells maintain proteostasis and respond to stress.\"},{\"question\":\"Why are tumor cells highly dependent on HSP90?\",\"answer\":\"In cancer, HSP90 helps maintain oncogenic signaling, buffers proteotoxic stress, and supports survival under therapeutic insults, thereby promoting therapeutic resistance and recurrence.\"},{\"question\":\"What challenges have limited early HSP90 inhibitor development?\",\"answer\":\"Early HSP90 inhibitors, including geldanamycin and derivatives, faced dose-limiting systemic toxicities and unintended activation of a compensatory heat shock response that can reduce antitumor efficacy and support adaptive resistance.\"}]","Heat Shock Protein 90: From Molecular Chaperone Function to Therapeutic Targeting in Malignancies | PDF",1790103806,71,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df59f566c01c54340e2af61bcea1a2d5.webp",983,1283,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/484f607d300c8d9810a1ceca0e2b3630.webp",982,1281,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de5e96cbc97d6fcb41cf1fb08cd85718.webp",981,1280,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4317872bb7b9711da102c872e5533f38.webp",980,1279]